P544: Exome sequencing in a national public system: Real-world outcomes from a Brazilian NDD cohort
Abstract
Exome sequencing (ES) is established as a first-tier diagnostic test for neurodevelopmental disorders (NDD). However, publicly funded implementation in the Brazilian National Health System has only recently begun. Real-world evidence is essential to guide national policies and equitable access. We report early outcomes of ES during its initial deployment at a Public Reference Center for Rare Diseases in Southern Brazil.
Fields of Study & Subjects
Genomics and Rare Diseases
Genetics and Neurodevelopmental Disorders
Autism Spectrum Disorder Research
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 104036–104036
- Publication date
- 1 January 2026
- Language
- EN